Gladstone Institutional Advisory’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41K | Hold |
13,000
| – | – | ﹤0.01% | 749 |
|
|
2025
Q1 | $40.8K | Hold |
13,000
| – | – | ﹤0.01% | 710 |
|
|
2024
Q4 | $56.4K | Sell |
13,000
-2,000
| -13% | -$8.68K | ﹤0.01% | 692 |
|
|
2024
Q3 | $40.1K | Hold |
15,000
| – | – | ﹤0.01% | 677 |
|
|
2024
Q2 | $33.3K | Hold |
15,000
| – | – | ﹤0.01% | 654 |
|
|
2024
Q1 | $80.1K | Hold |
15,000
| – | – | ﹤0.01% | 627 |
|
|
2023
Q4 | $22.2K | Hold |
15,000
| – | – | ﹤0.01% | 663 |
|
|
2023
Q3 | $20.9K | Buy |
15,000
+1,000
| +7% | +$1.39K | ﹤0.01% | 616 |
|
|
2023
Q2 | $20.6K | Hold |
14,000
| – | – | ﹤0.01% | 625 |
|
|
2023
Q1 | $23.1K | Hold |
14,000
| – | – | ﹤0.01% | 648 |
|
|
2022
Q4 | $19.6K | Hold |
14,000
| – | – | ﹤0.01% | 638 |
|
|
2022
Q3 | $22K | Buy |
+14,000
| New | +$22K | ﹤0.01% | 625 |
|